Measuring cellular contraction: Current progress and a future in bioelectronics

Pancreatic Cancer: Current Progress and Future Challenges.

Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, remains one of the highly lethal malignancies. The highly refractory nature of clinically advanced disease and lack of a reliable biomarker for early detection are major obstructions in improving patient outcome. The recent efforts, however, in understanding the pancreatic tumor biology have resulted in the reco...

Uterus transplantation: current progress and future prospects

Even if reproductive medicine has been remarkably successful during the past few decades, with the introduction of in vitro fertilization in the late 1970s and intracytoplasmic sperm injection in the early 1990s, it has been repeatedly mocked by infertility due to an absolute uterine factor. No treatment has been available for the women suffering from an absent or dysfunctional uterus, in terms...

Bioconjugate Therapeutics: Current Progress and Future Perspective.

Polyolefin and olefin production in Iran: Current and future capacities

Due to easy availability of cheaper raw material and increase in new applications, the use of polyolefins in various industries is becoming a major priority. The Middle East region, on account of its vast oil and gas reserves has, in the last decade or so, been developing many new petrochemical complexes with their expansion into colossal polyolefin production capacities. The predictions are th...

Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives

Lung cancer is the most common cancer in the world. Despite modern advancements in surgeries, chemotherapies, and radiotherapies over the past few years, lung cancer still remains a very difficult disease to treat. This has left the death rate from lung cancer victims largely unchanged throughout the past few decades. A key cause for the high mortality rate is the drug resistance that builds up...